Enhancing Prospective Thinking in Early Recovery (PARK)

Launched by INDIANA UNIVERSITY · Jun 8, 2023

Keywords

ClinConnect Summary

The PARK clinical trial is studying a new virtual reality (VR) program designed to help people in early recovery from opioid use disorder. The main goal is to see if using VR can reduce the number of days a person uses opioids and encourage longer periods of staying sober. Researchers will compare participants who use the VR program with those who do not to see if the VR group has better outcomes in terms of reducing opioid use, staying abstinent, and focusing on future goals.

To be eligible for this study, participants need to be between 18 and 60 years old, have been abstinent from opioids for at least 14 days but less than one year, and be committed to their recovery. Participants should also be able to understand English. Those with serious medical or psychiatric issues, or who are outside the age range, will not be included. If you join the study, you can expect to engage with the VR program and provide feedback about your experiences and recovery over a 30-day period. The trial is currently recruiting participants and aims to gather important information to potentially develop this innovative treatment further.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Abstinence between ≥14 days and ≤ 1 year
• • 18-60 years old
• • Verbal endorsement of commitment to recovery
• • Outpatient
• • Psychotropic drugs for SUD-comorbidity
• • Mu-Opioid drugs
• • Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit
• • English comprehension
• Exclusion Criteria:
• • Unstable medical disorders
• • Outside the age range of 18-60
• • Habitual drug use
• • Smell/taste disorders
• • Unstable psychiatric conditions
• • Extravagant/elaborate face tattoos